Abstract 950: Targeting B7-H3 in squamous cell carcinoma of the head and neck: Preclinical proof-of-concept with the investigational anti-B7-H3 antibody-drug conjugate, MGC018

2021 ◽  
Author(s):  
Juniper A. Scribner ◽  
Francine Z. Chen ◽  
Ying Li ◽  
Michael Chiechi ◽  
Thomas Son ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Proof Of Concept ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug

Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma

Oral Oncology ◽  
2018 ◽  
Vol 80 ◽  
pp. 33-39 ◽  
Author(s):  
Saskia H. Hanemaaijer ◽  
Stephanie E. van Gijn ◽  
Sjoukje F. Oosting ◽  
Boudewijn E.C. Plaat ◽  
Kirsten L. Moek ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Data Driven ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug

scholarly journals A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma

Oral Oncology ◽  
2013 ◽  
Vol 49 (10) ◽  
pp. 991-997 ◽  
Author(s):  
Larissa Sweeny ◽  
Yolanda E. Hartman ◽  
Kurt R. Zinn ◽  
James R. Prudent ◽  
David J. Marshall ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Drug Conjugate
Sign in / Sign up

Export Citation Format

Share Document